Exploiting altered glycosylation patterns in cancer: Progress and challenges in diagnosis and therapy
- 1 June 1994
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 12 (6) , 227-233
- https://doi.org/10.1016/0167-7799(94)90121-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) AntibodyNew England Journal of Medicine, 1993
- Mucin Genes and the Proteins They Encode: Structure, Diversity, and RegulationAmerican Journal of Respiratory Cell and Molecular Biology, 1992
- Active Immunization of Human Ovarian Cancer Patients Against a Common Carcinoma (Thomsen-Friedenreich) Determinant Using a Synthetic Carbohydrate AntigenJournal of Immunotherapy, 1992
- Why are proteins O-glycosylated?Trends in Biochemical Sciences, 1990
- Molecular changes in carbohydrate antigens associated with cancerBioEssays, 1990
- A short sequence, within the amino acid tandem repeat of a cancer‐associated mucin, contains immunodominant epitopesInternational Journal of Cancer, 1989
- Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate AntigensAdvances in Cancer Research, 1989
- T and Tn, General Carcinoma AutoantigensScience, 1984
- TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURSThe Lancet, 1982
- LIPOSOMALLY ENTRAPPED SECOND ANTIBODY IMPROVES TUMOUR IMAGING WITH RADIOLABELLED (FIRST) ANTITUMOUR ANTIBODYThe Lancet, 1982